US biopharmaceutical firm Intarcia Therapeutics has appointed John Yee as Vice President, Head of Global Medical Affairs, Safety and Operations, a newly created position.
Yee has two decades of experience at leading pharmaceutical, biotechnology, and healthcare companies, and at an academic medical centre.
Most recently Yee was VP, Head of Medical Affairs, US Diabetes, and VP, US Head Medical Officer at AstraZeneca, where he led medical affairs across all therapeutic areas, and the medical launch of multiple cardiovascular and metabolic products.
In his career prior to AstraZeneca, Yee served in progressive leadership roles at Genzyme, including Global Medical Director; VP, US Medical Affairs; and VP, Global Medical Affairs for the company's rare genetic disease business and VP, Global Head, Evidence-Based Medicine across all therapeutic areas.
In his new role, Yee will be a member of the leadership team and an executive officer of the company, reporting to Kurt Graves, Chairman, President and CEO.
